Home Tools
Log in
Cart

Cediranib

Catalog No. T2500   CAS 288383-20-0
Synonyms: AZD2171, NSC-732208

Cediranib (AZD2171) (AZD2171) is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro, also inhibits Flt1/4 (IC50: 5 nM/≤3 nM), similar activity against PDGFRβ and c-Kit, selective more for VEGFR than PDGFR-α (36-fold), CSF-1R (110-fold), and Flt3 (1000-fold) in HUVEC cells.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Cediranib Chemical Structure
Cediranib, CAS 288383-20-0
Pack Size Availability Price/USD Quantity
2 mg In stock $ 35.00
5 mg In stock $ 57.00
10 mg In stock $ 84.00
25 mg In stock $ 138.00
50 mg In stock $ 187.00
100 mg In stock $ 267.00
200 mg In stock $ 487.00
500 mg In stock $ 782.00
1 mL * 10 mM (in DMSO) In stock $ 63.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 99.94%
Purity: 99.78%
Purity: 97.21%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description Cediranib (AZD2171) (AZD2171) is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro, also inhibits Flt1/4 (IC50: 5 nM/≤3 nM), similar activity against PDGFRβ and c-Kit, selective more for VEGFR than PDGFR-α (36-fold), CSF-1R (110-fold), and Flt3 (1000-fold) in HUVEC cells.
Targets&IC50 FLK1:5 nM, FLT4:≤3 nM
In vitro Cediranib exhibits highly effective and dose-dependent activity in human xenograft models. Additionally, Cediranib induces vascular regression in human lung cancer xenografts. It causes excessive skeletal growth, obstructs the production of corpora lutea in the ovaries, and inhibits physiological processes that are dependent on angiogenesis.
In vivo In vitro, Cediranib directly inhibits the proliferation of tumor cells and blocks microtubule formation, while also suppressing angiogenesis induced by VEGF in vivo. Cediranib exhibits inhibition against bFGF (IC50: 0.5 μM) and EGF (IC50: 0.11 μM), and in the MG63 cell line, it inhibits PDGF-AA (IC50: 0.04 μM). Furthermore, Cediranib suppresses Flt-1 associated kinases (IC50: 5 nM) and exhibits inhibitory effects on the VEGF-C and VEGF-D receptors, Flt-4 (IC50 < 3 nM), in addition to inhibiting the tyrosine kinases c-Kit (IC50: 2 nM) and PDGFR-β (IC50: 5 nM).
Kinase Assay Kinase inhibition: Cediranib is dissolved in DMSO at a concentration of 10 mM. All enzyme assays are run at, or just below, the respective Km for ATP (0.2 - 30 μM). The inhibitory activity of Cediranib is determined against a range of recombinant tyrosine kinases [KDR, Flt-1, Flt-4, c-Kit, PDGFRα, PDGFRβ, CSF-1R, Flt-3, FGFR1, Src, Abl, epidermal growth factor receptor (EGFR), ErbB2, Aurora A, and Aurora B] using ELISA. Selectivity versus CDK2 and CDK4 serine/threonine kinases is examined using scintillation proximity assays with a retinoblastoma substrate and [γ-sup>33P]ATP. Activity of Cediranib is compared to MAPK kinase (MEK), which shows dual specificity. It is determined using a MAPK substrate, [γ-33P]ATP, and paper capture/scintillation counting.
Cell Research The proliferation of the HUVEC cell line is evaluated in the presence and absence of growth factors by measuring 3H-thymidine incorporation following a 4-day incubation period. Proliferation of MG63 osteosarcoma cells is induced by PDGF-AA, which selectively activates signaling of the PDGFRα homodimer. HUVEC and MG63 osteosarcoma cells are cultured in DMEM without phenol red containing 1% charcoal stripped FCS, 2 mM glutamine, and 1% nonessential amino acids for 24 hours. Cediranib or vehicle is added with PDGF-AA ligand (50 ng/mL) and plates incubated for another 72 hours. Cellular proliferation is determined using bromodeoxyuridine ELISA. (Only for Reference)
Synonyms AZD2171, NSC-732208
Molecular Weight 450.51
Formula C25H27FN4O3
CAS No. 288383-20-0

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

H2O: < 1 mg/mL (insoluble or slightly soluble)

DMSO: 83 mg/mL (184.2 mM)

Ethanol: < 1 mg/mL (insoluble or slightly soluble)

TargetMolReferences and Literature

1. Wedge SR, et al. Cancer Res, 2005, 65(10), 4389-4400. 2. Morton CL, et al. Pediatr Blood Cancer, 2012, 58(4), 566-571.

TargetMolCitations

1. Zhang J, Guo H, Wang L, et al.Cediranib enhances the transcription of MHC-I by upregulating IRF-1.Biochemical Pharmacology.2024: 116036.

Related compound libraries

This product is contained In the following compound libraries:
Membrane Protein-targeted Compound Library Anti-Cancer Clinical Compound Library FDA-Approved Kinase Inhibitor Library Highly Selective Inhibitor Library Inhibitor Library Anti-Cancer Drug Library Anti-Cancer Approved Drug Library Drug Repurposing Compound Library Kinase Inhibitor Library Tyrosine Kinase Inhibitor Library

Related Products

Related compounds with same targets
VEGFR2-IN-3 ENMD-2076 Parsatuzumab Ranibizumab Vatalanib dihydrochloride Taxifolin Lenvatinib mesylate Myricanol

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

Cediranib 288383-20-0 Angiogenesis Autophagy Tyrosine Kinase/Adaptors VEGFR FLT PDGFR c-Kit Platelet-derived growth factor receptor Vascular endothelial growth factor receptor inhibit AZD2171 NSC-732208 NSC732208 AZD 2171 NSC 732208 AZD-2171 Inhibitor inhibitor

 

TargetMol